Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Priority review granted to antihypertensive drug Vanlev

Jan. 11, 2000

Human Genome Sciences discloses novel growth-regulatory protein, its production and use

Jan. 11, 2000

PR39 induces therapeutic angiogenesis in preclinical models

Jan. 10, 2000

New series of NOS inhibitors in early development at Pfizer

Jan. 6, 2000

CV Therapeutics establishes Tangier drug discovery program

Jan. 5, 2000

Calcineurin inhibitor FK-506 prevents cardiac hypertrophy in rats

Jan. 4, 2000

NEP inhibition with candoxatrilat increases renal response in mild CHF

Jan. 4, 2000

Nonpeptide endothelin antagonists from Warner-Lambert selective for ETA receptors

Jan. 3, 2000

Cell Based Delivery receives NIST grant for cardiovascular program

Jan. 3, 2000

Benzofurans with cardioprotective, anxiolytic activity designed at Egis

Dec. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...